Advertisement

Spontaneous regression of a clival chordoma. Case report

  • Evan D. Bander
  • Gary Kocharian
  • Benjamin Liechty
  • Apostolos J. Tsiouris
  • Theodore H. SchwartzEmail author
Case Report - Brain Tumors
Part of the following topical collections:
  1. Brain tumors

Abstract

In this case report, we present a rare and previously unreported case of spontaneous regression of a histologically consistent clival chordoma. At the time of diagnosis, imaging demonstrated a T2 hyperintense and T1 isointense midline skull base mass, centered in the nasopharynx, with scalloping of the ventral clivus consistent with a chordoma measuring 3.1 × 1.9 × 3.0 cm (8.84 cm3). On pre-operative imaging 2 months later, with no intervening therapy, the mass had regressed by 61.7% to a size of 2.3 × 2.1 × 1.4 cm (3.38 cm3). The patient self-administered several herbal supplements and animal oils which may have contributed to tumor regression. The purpose of this report is to document this rare occurrence and provide a comprehensive description of the case details and list of the various medications, herbs, and supplements used prior to this rare event.

Keywords

Chordoma Spontaneous Regression 

Notes

Compliance with ethical standards

The patient has consented to the submission of the case report for publication.

References

  1. 1.
    Azzarelli A, Quagliuolo V, Cerasoli S, Zucali R, Bignami P, Mazzaferro V, Dossena G, Gennari L (1988) Chordoma: natural history and treatment results in 33 cases. J Surg Oncol 37(3):185–191CrossRefGoogle Scholar
  2. 2.
    Ban TA (2006) The role of serendipity in drug discovery. Dialogues Clin Neurosci 8(3):335–344PubMedPubMedCentralGoogle Scholar
  3. 3.
    Boari N, Gagliardi F, Cavalli A, Gemma M, Ferrari L, Riva P, Mortini P (2016) Skull base chordomas: clinical outcome in a consecutive series of 45 patients with long-term follow-up and evaluation of clinical and biological prognostic factors. J Neurosurg 125(2):450–460CrossRefGoogle Scholar
  4. 4.
    Coley WB (1991) The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. Clin Orthop (262):3–11Google Scholar
  5. 5.
    Di Maio S, Temkin N, Ramanathan D, Sekhar LN (2011) Current comprehensive management of cranial base chordomas: 10-year meta-analysis of observational studies. J Neurosurg 115(6):1094–1105CrossRefGoogle Scholar
  6. 6.
    Erdem E, Angtuaco EC, Van Hemert R, Park JS, Al-Mefty O (2003) Comprehensive review of intracranial chordoma. RadioGraphics 23(4):995–1009CrossRefGoogle Scholar
  7. 7.
    Heffelfinger MJ, Dahlin DC, MacCarty CS, Beabout JW (1973) Chordomas and cartilaginous tumors at the skull base. Cancer 32(2):410–420CrossRefGoogle Scholar
  8. 8.
    Kitai R, Yoshida K, Kubota T, Sato K, Handa Y, Kasahara K, Nakajima H (2005) Clival chordoma manifesting as nasal bleeding. A case report. Neuroradiology 47(5):368–371CrossRefGoogle Scholar
  9. 9.
    Lagman C, Varshneya K, Sarmiento JM, Turtz AR, Chitale RV Proposed diagnostic criteria, classification schema, and review of literature of notochord-derived ecchordosis physaliphora. Cureus.  https://doi.org/10.7759/cureus.547
  10. 10.
    McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM (2001) Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control CCC 12(1):1–11CrossRefGoogle Scholar
  11. 11.
    Meng T, Jin J, Jiang C, Huang R, Yin H, Song D, Cheng L (2019) Molecular targeted therapy in the treatment of chordoma: a systematic review. Front Oncol 9:30CrossRefGoogle Scholar
  12. 12.
    Mobley BC, McKenney JK, Bangs CD et al (2010) Loss of SMARCB1/INI1 expression in poorly differentiated chordomas. Acta Neuropathol (Berl) 120(6):745–753CrossRefGoogle Scholar
  13. 13.
    Moore KA, Bohnstedt BN, Shah SU, Abdulkader MM, Bonnin JM, Ackerman LL, Shaikh KA, Kralik SF, Shah MV (2015) Intracranial chordoma presenting as acute hemorrhage in a child: case report and literature review. Surg Neurol Int.  https://doi.org/10.4103/2152-7806.155445 CrossRefGoogle Scholar
  14. 14.
    Nishiguchi T, Mochizuki K, Ohsawa M, Inoue T, Kageyama K, Suzuki A, Takami T, Miki Y (2011) Differentiating benign notochordal cell tumors from chordomas: radiographic features on MRI, CT, and tomography. Am J Roentgenol 196(3):644–650CrossRefGoogle Scholar
  15. 15.
    Radl R, Leithner A, Kastner N, Bodo K, Nader A, Windhager R (2005) Disappearance of a cervical spine chordoma after nonoperative treatment. A case report. J Bone Joint Surg Am 87(8):1822–1827CrossRefGoogle Scholar
  16. 16.
    Walcott BP, Nahed BV, Mohyeldin A, Coumans J-V, Kahle KT, Ferreira MJ (2012) Chordoma: current concepts, management, and future directions. Lancet Oncol 13(2):e69–e76CrossRefGoogle Scholar
  17. 17.
    Zou Y, Neale N, Sun J et al (2018) Prognostic factors in clival chordomas: an integrated analysis of 347 patients. World Neurosurg 118:e375–e387CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2019

Authors and Affiliations

  • Evan D. Bander
    • 1
  • Gary Kocharian
    • 1
  • Benjamin Liechty
    • 2
  • Apostolos J. Tsiouris
    • 3
  • Theodore H. Schwartz
    • 1
    Email author
  1. 1.Department of NeurosurgeryWeill Cornell Medicine, New York Presbyterian HospitalNew YorkUSA
  2. 2.Department of PathologyWeill Cornell Medicine, New York Presbyterian HospitalNew YorkUSA
  3. 3.Department of RadiologyWeill Cornell Medicine, New York Presbyterian HospitalNew YorkUSA

Personalised recommendations